Given that rosiglitazone affects multiple organs and acts as an insulin sensitizer, it is not clear whether correction of hyperglycemia is the only factor responsible for the upregulation of renal NEP protein expression observed in db/db mice (Alawi et al., 2020). This evidence concerns the gene MME and Hyperglycemia.